Orbital IgG4-related disease

41
Orbital IgG4- Related Disease Raed Behbehani , MD FRCSC

Transcript of Orbital IgG4-related disease

Page 1: Orbital IgG4-related disease

Orbital IgG4-Related Disease

Raed Behbehani , MD FRCSC

Page 2: Orbital IgG4-related disease

Case• A 36 year old Philippino : acute painful loss of vision and

droopy lid in the right eye.

• H/O right 6th nerve palsy 2 years ago , MRI showed right cavernous sinus and sphenoid sinus lesion.

• He was referred to ENT later by ENT and then was lost to follow up by me.

• Recent contact with ENT : biopsy was “non-specific inflammatory” and was treated with oral steroids only.

• PMH : no TB

• Social history : Smoker for 15 years

Page 3: Orbital IgG4-related disease

Case• VA : HM recognition OD , 20/20 OS.

• TA : 14 mm/Hg OU.

• Pupils : large right RAPD

• Complete ptosis and severe limitation of eye movement in all gaze direction OD.

• Anterior and posterior segment normal OU.

• Humphrey automated visual field testing was normal OS.

Page 4: Orbital IgG4-related disease

MRI

Page 5: Orbital IgG4-related disease

MRI

Page 6: Orbital IgG4-related disease

Investigations• PPD : negative

• Serum ACE : 20 U/L (range 8-52 U/L)

• C-ANCA : 4 U/ml (normal < 23 U/ml)

• (P-ANCA) : 1 U/ml (normal < 22 U/ml).

• Chest x-ray was normal

• Gallium 67 scan : no uptake in the lacrimal gland, parotid gland or mediastinum.

Page 7: Orbital IgG4-related disease

Management

• Rx : IV methylprednisolone 1 gram/day for 5 days followed by oral steroids 1 mg/Kg.

• Improvement in his ptosis and ocular motility.

• Visual acuity deteriorated to LP OD

• Neurosurgical consultation to obtain a dural biopsy.

• Dura Histology : “Patchy lymphocytic infiltration” few plasma cells.

Page 8: Orbital IgG4-related disease

Follow up

• Presented 2 months later with sudden decrease in vision OS !

• VA was light perception OD and hand motion recognition OS !

• Pupils : bilaterally sluggish.

• Normal lids and full ocular motility and intact corneal reflexes and facial sensation.

• Fundoscopy : optic nerve pallor OD , normal optic nerve OS.

Page 9: Orbital IgG4-related disease

Follow up MRI

Page 10: Orbital IgG4-related disease

Follow up MRI

Page 11: Orbital IgG4-related disease

Follow up

• VDRL , TPHA, and HIV serology : negatives.

• Lumbar puncture : normal CSF analysis (cells , glucose , protein) and negative staining for AFB , no fungus and negative bacterial culture growth.

• IV steroids

• Review initial specimen of the paranasal polyp biopsy.

Page 12: Orbital IgG4-related disease

Pathology

H&E stain x400 Masson’s Trichrome Stain x 100

Page 13: Orbital IgG4-related disease

Pathology

IgG4 positive plasma cells 80/hpf (x 400).

Page 14: Orbital IgG4-related disease

Follow Up

• Dx : Orbital and intracranial IgG4-related disease

• He received two infusion of 1000 mg IV Rituximab.

• Two months following Rituximab infusion, his serum IgG 4 was elevated at 1440 mg/L (normal 39.2-864 mg/L).

• 6/12 later (2nd infusion Rituximab) : VA NLP OD VA 20/40 OS.

Page 15: Orbital IgG4-related disease

Follow up MRI

May 2014 October 2014

Page 16: Orbital IgG4-related disease

Case

• A 32 with recurrent bilateral painless orbital swelling and puffiness for 3 years.

• Severe asthma for 3 years and with that he noticed resolution of eye swelling with oral steroids.

• Significant peripheral esinophilia and high IgE level necessitating treatment with anti IgE therapy.

Page 17: Orbital IgG4-related disease

Case

Both lacrimal glands were palpable and firm

No other palpable masses or lymphadenopathy or any skin lesions

Page 18: Orbital IgG4-related disease

CT

2014

Page 19: Orbital IgG4-related disease

CT

2010

Page 20: Orbital IgG4-related disease

Case

• IgG 24.1 g/L (6-16g/L) , IgG4 >1440 mg/L ( 39.2- 864 mg/L).

• ANA, p-ANCA ,c-ANCA - negative

• Bilateral lacrimal gland biopsy performed.

• Biopsy - high IgG4 plasma cell infiltrate.

Page 21: Orbital IgG4-related disease

Case

Oral steroids (Recurrence)IV Rituximab

Page 22: Orbital IgG4-related disease

IgG4-RD• An inflammatory condition of unknown etiology.• Autoimmune pancreatitis (AIP) with elevated serum

IgG4 levels and later systemic lesions found (Hamano H et al. NEJM 2001)

• Tumefactive lesions in a number of tissues and organs.

• Diagnosis is established by IgG4-bearing plasma cells in addition to characteristic morphologic features, with or without elevated serum IgG4.

2,

Page 23: Orbital IgG4-related disease

Mikulicz

Johann von Milulicz-Radecki , 1888

Page 24: Orbital IgG4-related disease

IgG4-RD

Mickulicz disease, Kuttner tumor (sclerosing sialadenitis)Riedel thyroiditismultifocal fibrosclerosisOrmond disease (idiopathic retroperitoneal fibrosis)Aortitis, periaortitis Retroperitoneal fibrosis, Eosinophilic angiocentric fibrosis (EAF)

Page 25: Orbital IgG4-related disease

Diagnosis

Page 26: Orbital IgG4-related disease

Orbital IgG4-RD and AIP

• 50% of patients with Orbital IgG4-RD will have systemic lesions (salivary gland, liver , pituitary , pancreas, retroperitoneeum) .

• 20-45% of patients with AIP will have orbital IgG4-RD.

Page 27: Orbital IgG4-related disease

Orbital IgG4-RD• Clinically can be confused with idiopathic

orbital inflammatory (IOI) , infectious and neoplastic conditions.

• Many patients with IOI do not undergo biopsy and even if done biopsy is no stained routinely for IgG4.

• Many cases of IOI represent misdiagnosed IgG-RD. (Geyer et al. 2010).

Page 28: Orbital IgG4-related disease

Patterns or Orbital IgR4-RD

1) IgG-4 Dacryoadenitis (62%-88) (Sogabe et al. Wallace et al. Sato et al. )

2) Enlargement of orbital nerves (V2) associated with orbital

myositis and lacrimal gland disease, +_ with paranasal sinus

disease, eosinophilia, and systemic involvement; and

3) Sclerosing orbital inflammation

4) Optic nerve involvement

5) Ocular adnexal involvement

Page 29: Orbital IgG4-related disease

IgG4-RD Darcyoadenitis

• The most common maniesfation of orbital Ig4-RD (62%-88) (Sogabe et al. Wallace et al)

• Unilateral , Bilateral • History of allergy with an elevated IgE

levels (50%) .

Page 30: Orbital IgG4-related disease

Enlargement of the Infra-orbital Nerve

• In 39% of cases (Sogabe et al.) usually with EOM and Sinus involvement.

• In 20 of 68 patients with “Miculikz IgG-4 RD”. (Takano K at al. 2014)

• In 20 of the 28 eyes with either RLH or IgG4-RD. (Hardy et al. Ophthalmology 2014)

• Incidence higher in IgG4-ROD patient group than non-IgG4-ROD (p < 0.0001). (Ohshima et al. 2012)

• No sensory disturbance.

Page 31: Orbital IgG4-related disease

IgG4-RD vs IOIIgR4-RD

Idiopathic Orbital

InflammationMode of Onset Chronic Acute-Subacute

Pain - + severe

Laterality Bilateral Unialteral

Infra-orbital nerve

enlargement+ pathognomonic -

Associated systemic diseases

Allergic rhinitis, asthma rare

Other organ involvement

AIP, sclerosing cholangitis,

retoperitoneal fibrosis -

Page 32: Orbital IgG4-related disease

Optic Neuropathy

• Usually compressive (enlarged V2, enlarged EOM, fat, mass)

• Infiltrative or inflammatory.

Page 33: Orbital IgG4-related disease

Ocular Adnexal IgG4-RD

• Orbital Myositis• Lacrimal Sac• Conjunctiva and sclera

Page 34: Orbital IgG4-related disease

Orbital IgG4-RD Mimickers

Andrew NH, BJO 2015

Page 35: Orbital IgG4-related disease

Pathology

lymphocytic infiltrates are usually composed ofreactive lymphoid follicles with germinal centers + plasma cells ( +- Arteritis +_ Eosinophlis)Storiform fibrosis

Page 36: Orbital IgG4-related disease

Pathology (IgG4 Stain)

• No of IgG4-positive cells is variable (>= 10 cells/hpf).

• In lacrimal glands (100/hpf).

• Depends on fibrosis (sclerosing IOI) , amount of systemic lesions, and serum IgG4.

• IgG4+/IgG+ plasma cell ratio (>40%)

Page 37: Orbital IgG4-related disease

Orbital IgG4-RD and Lymphoma

• 44 of 448 (9.8%) cases of extranodal marginal B-cell lymphoma of (MALT) type had IgG4+ plasma cell infiltrates. (Japanese Study Group of IgG4-Related Ophthalmic Disease. . Jpn J Ophthalmol. 2013)

Page 38: Orbital IgG4-related disease

Pathogenesis• Abnormal immune response to food

and environmental agents (microbes or tissue damage) .

• Humoral auto-immunity (B-cells) : response to Rituximab.

• Increased mRNA levels of cytokines IL-4,IL-5, and IL-13, suggestive of Th2 cell response (atopy).

• Low levels of C3,C4.

Page 39: Orbital IgG4-related disease

Treatment• Steroids have been the mainstay

of treatment.• Relapses common (50%).• Serum IgG4 fall with steroid

therapy.• Steroid-spraing (azathioprine,

methotrexate, and mycophenolate)

Page 40: Orbital IgG4-related disease

Anti-CD 20 (Rituximab)

• Many series shown dramatic response.

• Relapses occurred when B-cells recovered after 6 months, and responded well to a repeat dose.

• Single-dose Rituximab can be effective sometimes.

Page 41: Orbital IgG4-related disease

Summary• Orbital IgG4-RD can present with

inflammtion of the orbit and ocular adnexa.• Clinical should keep high-index of suspicion. • Orbital IgG4-RD has distinctive pathologic

features.• Good communication with a pathologist is

essential.• Steroids and anti-CD 20 can be useful in

treatment.